WHO Model Lists of Essential Medicines: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 38: | Line 38: | ||
*[[Gefitinib]] | *[[Gefitinib]] | ||
*[[Ibrutinib]] | *[[Ibrutinib]] | ||
*[[Ibuprofen]] | |||
*[[Imatinib]] | *[[Imatinib]] | ||
*[[Insulin glargine]] | *[[Insulin glargine]] | ||
Revision as of 13:39, 11 January 2024
WHO Model Lists of Essential Medicines:
- Abiraterone acetate
- Acetazolamide
- Acetylsalicylic Acid (Aspirin)
- Aciclovir
- Afatinib
- Amiodarone
- Amlodipine
- Apixaban
- Aprepitant
- Aripiprazole
- Asparaginase
- Atazanavir + ritonavir
- Atorvastatin
- Atorvastatin + perindopril + amlodipine
- Atropine
- Azithromycin
- Bedaquiline
- Bevacizumab
- Bicalutamide
- Budesonide
- Budesonide + formoterol
- Clarithromycin
- Clomipramine
- Ciprofloxacin
- Cisplatin
- Darunavir
- Dasatinib
- Efavirenz + Emtricitabine + Tenofovir
- Emtricitabine
- Enalapril
- Erlotinib
- Ethambutol
- Fluoxetine
- Fluvastatin
- Formoterol
- Gefitinib
- Ibrutinib
- Ibuprofen
- Imatinib
- Insulin glargine
- Lidocaine
- Lisinopril + amlodipine
- Lisinopril + hydrochlorothiazide
- Lopinavir + ritonavir
- Metformin
- Methotrexate
- Nilotinib
- Pembrolizumab
- Perindopril
- Propranolol
- Pyrazinamide
- Raltegravir
- Ramipril
- Ribavirin
- Ritonavir
- Rituximab
- Sertraline
- Simvastatin
- Tamoxifen
- Timolol
- Tiotropium bromide
- Trastuzumab
